Skip to main content
. Author manuscript; available in PMC: 2009 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):572–576. doi: 10.1097/QAI.0b013e31817bbc4e

Table 2.

Fitness difference of V38A mutants relative to wild-type virus for periods on and off enfuvirtide therapy.

Fitness Difference a

Subject −ENF + ENF
1 −54% ± 6% +498% ± 316%
2 −35% ± 4% +107% ± 20%
3 First interruption −25% ± 2% +235% ± 85%
Second interruption −65% ± 9% n.d.

ENF, enfuvirtide; n.d., not done.

a

Fitness differences were determined following enfuvirtide interruption (−ENF) or during a four-week period of enfuvirtide “pulse” therapy (+ENF).